Salarius Pharmaceuticals, Inc. (DCOY)

CIK 1615219 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Salarius Pharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
Oct 16, 2026EFFECT9999999995-26-003278
Oct 16, 2026424B30001193125-26-424075
Oct 7, 2026S-10001193125-26-417053
Sep 23, 20268-K0001615219-26-000019
Sep 15, 20268-K0001615219-26-000016
Sep 2, 202640002079512-26-000002
Sep 2, 202640001229055-26-000002
Sep 2, 202640002079859-26-000002
Sep 2, 202640001329154-26-000003
Sep 2, 202640001769749-26-000003
Sep 2, 202640002148287-26-000002
Sep 2, 202640001233253-26-000006
Sep 2, 202640001457289-26-000003
Sep 2, 202640001193125-26-380584
Sep 2, 202640001634368-26-000003
Aug 14, 2026SCHEDULE 13G0001172661-26-003569
Aug 12, 202610-Q0001193125-26-346852
Aug 4, 2026DEFA14A0001193125-26-332792
Aug 4, 2026DEF 14A0001193125-26-332762
Jul 31, 202630001193125-26-328787
Jul 24, 2026PRE 14A0001193125-26-316072
Jul 17, 2026424B30001193125-26-307982
Jul 17, 2026EFFECT9999999995-26-002352
Jul 15, 20268-K0001193125-26-304949
Jul 10, 2026S-10001193125-26-300954